Neoadjuvant radiotherapy combined with capecitabine and sorafenib in patients with advanced KRAS-mutated rectal cancer: A phase I/II trial (SAKK 41/08).

von Moos, Roger, Koeberle, Dieter, Schacher, Sabina, Hayoz, Stefanie, Winterhalder, Ralph C, Roth, Arnaud, Bodoky, György, Samaras, Panagiotis, Berger, Martin Dave, Rauch, Daniel, Saletti, Piercarlo, Plasswilm, Ludwig, Zwahlen, Daniel, Meier, Urs R, Yan, Pu, Izzo, Paola, Klingbiel, Dirk, Bärtschi, Daniela, Zaugg, Kathrin

Open source

DOI: 10.7892/boris.108158
Published: 2018
Container: Not recorded
Publisher: University of Bern
Open access: no

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
supportingPublication license: A publication license was supplied: http://purl.org/coar/access_right/c_16ec. Presence improves reuse transparency, not research validity. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.7892/boris.108158,
  title = {Neoadjuvant radiotherapy combined with capecitabine and sorafenib in patients with advanced KRAS-mutated rectal cancer: A phase I/II trial (SAKK 41/08).},
  author = {von Moos, Roger and Koeberle, Dieter and Schacher, Sabina and Hayoz, Stefanie and Winterhalder, Ralph C and Roth, Arnaud and Bodoky, György and Samaras, Panagiotis and Berger, Martin Dave and Rauch, Daniel and Saletti, Piercarlo and Plasswilm, Ludwig and Zwahlen, Daniel and Meier, Urs R and Yan, Pu and Izzo, Paola and Klingbiel, Dirk and Bärtschi, Daniela and Zaugg, Kathrin},
  year = {2018},
  doi = {10.7892/boris.108158},
  url = {https://doi.org/10.7892/boris.108158}
}

RIS

TY  - JOUR
TI  - Neoadjuvant radiotherapy combined with capecitabine and sorafenib in patients with advanced KRAS-mutated rectal cancer: A phase I/II trial (SAKK 41/08).
AU  - von Moos, Roger
AU  - Koeberle, Dieter
AU  - Schacher, Sabina
AU  - Hayoz, Stefanie
AU  - Winterhalder, Ralph C
AU  - Roth, Arnaud
AU  - Bodoky, György
AU  - Samaras, Panagiotis
AU  - Berger, Martin Dave
AU  - Rauch, Daniel
AU  - Saletti, Piercarlo
AU  - Plasswilm, Ludwig
AU  - Zwahlen, Daniel
AU  - Meier, Urs R
AU  - Yan, Pu
AU  - Izzo, Paola
AU  - Klingbiel, Dirk
AU  - Bärtschi, Daniela
AU  - Zaugg, Kathrin
PY  - 2018
DO  - 10.7892/boris.108158
UR  - https://doi.org/10.7892/boris.108158
ER  -

APA

Roger, V. M., Dieter, K., Sabina, S., Stefanie, H., C, W. R., Arnaud, R., György, B., Panagiotis, S., Dave, B. M., Daniel, R., Piercarlo, S., Ludwig, P., Daniel, Z., R, M. U., Pu, Y., Paola, I., Dirk, K., Daniela, B., & Kathrin, Z. (2018). Neoadjuvant radiotherapy combined with capecitabine and sorafenib in patients with advanced KRAS-mutated rectal cancer: A phase I/II trial (SAKK 41/08).. https://doi.org/10.7892/boris.108158

Source records

datacite · retrieved 2026-09-27T02:31:34.795Z